Visium Asset Management’s Novo Nordisk NVO Stock Holding History

Visium Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-262,408	Closed	-$5.55M	–	1143
2014 Q4	$5.55M	Buy	+262,408	New	+$5.86M	0.08%	237
2014 Q3	–	Sell	-39,066	Closed	-$902K	–	1165
2014 Q2	$902K	Buy	+39,066	New	+$863K	0.01%	557
2014 Q1	–	Sell	-90,860	Closed	-$1.68M	–	974
2013 Q4	$1.68M	Buy	90,860 +5,510	+6%	+$96K	0.03%	374
2013 Q3	$1.44M	Buy	85,350 +40,560	+91%	+$682K	0.03%	351
2013 Q2	$695K	Buy	+44,790	New	+$745K	0.02%	417

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Visium Asset Management's NVO Position: Q1 2015 in Review

Visium Asset Management sold out of Novo Nordisk (NVO) in Q1 2015, closing a stake of 262,408 shares — an estimated $5.55M sold.

Visium Asset Management first reported a position in NVO in Q2 2013 and held it in 5 quarters. The position peaked at $5.55M in Q4 2014. 505 funds tracked by Wall St. Rank hold NVO as of Q1 2015.

Visium Asset Management reported no remaining Novo Nordisk position as of Q1 2015 after selling out during the quarter.
Visium Asset Management sold 262,408 Novo Nordisk shares in Q1 2015, an estimated $5.55M.
Visium Asset Management first reported a position in Novo Nordisk in Q2 2013 and held it in 5 quarters.
Visium Asset Management's Novo Nordisk position peaked at $5.55M in Q4 2014.
505 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2015.

Based on Visium Asset Management's 13F filing for Q1 2015, filed 15 May 2015.